# Differential Cytokine and DNA Damage Response of Human Lung Tissue Models to Broad-Beam and Microbeam Radiotherapy

## TL;DR

This study compares the effects of different radiotherapy techniques on human lung tissue models, finding that microbeam therapy may reduce DNA damage and inflammation compared to traditional methods.

## Contribution

The study introduces a novel application of the EpiAlveolar™ model to compare broad-beam and microbeam radiotherapy effects on lung tissue.

## Key findings

- Ex vivo lung tissue can tolerate peak doses of 36 Gy with MRT-EUD and repair DNA damage effectively.
- MRT-valley irradiation leads to unresolved DNA damage 21 days post-treatment.
- Both BB and MRT-EUD groups show significant IL6 upregulation, but fibrotic collagen deposition is rare in MRT-treated tissues.

## Abstract

Radiotherapy (RT) is a standard treatment for lung cancer; however, radiation-induced toxicities such as pneumonitis and fibrosis limit dose escalation and tumor control. Therefore, improved RT approaches are needed. This study investigated the radiation response of human ex vivo normal lung tissue using the three-dimensional EpiAlveolar™ model. Tissue models were irradiated with broad-beam (BB) and two spatially fractionated microbeam radiation therapy (MRT) dose metrics: equivalent uniform dose (MRT-EUD) and valley dose (MRT-valley). Our findings show that ex vivo lung tissue is able to tolerate peak doses of 36 Gy following MRT-EUD. On day 21, models effectively repaired significant DNA double-strand break (DSB) damage seen in the MRT-EUD-irradiated peak regions. In contrast, persistent unresolved DSBs were detected in MRT-valley-irradiated models 21 days post irradiation. Prolonged culture time resulted in cell loss and a reduction in epithelial cell layers. A significant upregulation of the pro-inflammatory cytokine IL6 was observed in both BB and MRT-EUD groups at 21 days. Fibrotic collagen deposition was detected in one BB-irradiated model but was absent in remaining BB- and MRT-treated tissues. Further investigation is required to clarify the potential and suitability of EpiAlveolar™ models for studying radiation-induced lung injury.